Source: Rebel News

An email from Prime Minister Trudeau’s director of policy and cabinet affairs, Rick Theis, to Trudeau’s lead speechwriter, Astrid Krizus, about the ordering of pandemic supplies shows that the writer was suggested to make no mention of the Government of Canada’s purchase of hydroxychloroquine alongside other supplies, when preparing an official statement.

“Below… is the note PCO send [sic] to me on proposed language on PPE/supply,” Theis begins the email. He then relays two paragraphs of information that would seem to be guidance from the Privy Council Office with regard to how the federal government should word its announcement.

Interestingly, in the suggestions aimed at Krizus from the June 1, 2020 email, the speechwriter is told that it may not be best to focus on certain aspects of the government’s pandemic purchases.

“Some elements, we may not want to announce (e.g., the purchase of Hydroxylchloriquine [sic]),” the email notes.

“Thanks Rick,” Krizus replies.

Shortly after that email was sent, the government’s official position on the controversial usage of the drug was to not use it as a method of treatment for COVID-19.

Hydroxychloroquine became a topic of controversy following former U.S. president Donald Trump’s endorsement of the drug as a means for treating and staving off COVID-19. Having first touted the drug’s viability in April 2020, Trump then went on the record in May stating that he had been taking hydroxychloroquine in an effort to defend against the virus.

In June 2020, a study critical of hydroxychloroquine that was published in medical journal The Lancet was withdrawn. Another study released in July showed the anti-malarial drug “helped COVID-19 patients survive better,” according to a CNN report shared by MSN.

The drug would, yet again, be a topic of controversy in July 2020 following an announcement by a group of doctors, one of whom praised the drug for its ability to help those suffering from COVID-19.

The full email can be read below:










Related:
Journal of Medicine Says HCQ + Zinc Reduces COVID Deaths

HCQ Peer-reviewed: Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection

Perronne in the NEJM: ‘Recovery’ trial contested – is this finally a breach in the denial around hydroxychloroquine?

Craig Kelly MP, Dr Vladmir Zelenko and early treatment: ‘You don’t have to fall victim to your government’s tyranny’

Hydroxychloroquine & Covid-19: India and France, a cruel comparison

“COVID-19 AND HYDROXYCHLOROQUINE” I DO NOT REGRET ANYTHING “PROFESSOR RAOULT”

‘I base my comments on science’: Emeritus professor Robert Clancy defends hydroxychloroquine stance

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Dr. Harvey Risch: Hydroxychloroquine, Ivermectin, and Other Therapeutics Highly Effective in Early COVID Treatment

I’ve railed against this in the media that we are a part of, and the way that the propaganda reacts to this is, “Ignore it. Ignore all of this.” I’m saying this now because the general public has to be the one that gets angry. The general public should be furious at the way people have been treated in the country by suppression of these drugs, by that kind of website that suppresses the ability of doctors to practice medicine.

Read More »

A Judge Stands up to a Hospital: “Step Aside” and Give a Dying Man Ivermectin

The judge’s finest moment may have been when he dashed the most glaring myth about ivermectin—that it is not safe, despite decades of use that shows otherwise. Noting that all drugs have side effects, Judge Fullerton listed ivermectin’s effects from a government website.
“(N)umber one, generally well tolerated; number two, dizziness; number three, pruritus; number four, nausea/diarrhea. These are the side effects for the dosage that’s being asked to be administered,” he said. “The risks of these side effects are so minimal that Mr. Ng’s current situation outweighs that risk by one-hundredfold.”

Read More »